Skip to content

Ayahuasca prevents oxidative stress in a rat model of depression elicited by unpredictable chronic mild stress

LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) May 1, 2021 DOI: 10.15761/0101-60830000000286 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical study Peer reviewed
Population Adult male rats
Intervention Ayahuasca
Dose 500 mg/kg
Duration 15 days of administration before and during stress exposure
Topics Ayahuasca Depression
Citations 21
Key points Ayahuasca failed to prevent anhedonia-like behavior but counteracted stress-induced oxidative stress markers in the brain.

Abstract

ABSTRACT

Background: Depression is a highly disabling common mental disorder and, due to its multifactorial nature, the development of effective therapies is challenging and of great relevance. Ayahuasca (AYA), an entheogenic traditional beverage, has emerged as an alternative for antidepressant treatment, however, AYA preclinical and clinical trials are still incipient.

Objectives: This investigation aimed to evaluate some behavioral and biochemical effects of AYA subchronic administration in rats submitted to a model of depression elicited by unpredictable chronic mild stress (UCMS).

Methods: 500 mg/kg of AYA was administered in adult male rats once a day for 15 days before submitting the animals to UCMS. Anhedonia-like and locomotion behavior, lipid peroxidation, antioxidant enzyme activities, and sulfhydryl/nitrite content were evaluated.

Results: AYA intake failed to prevent anhedonia-like behavior. Locomotion was not altered by AYA consumption or by the experimental condition. UCMS increased TBARS and nitrites levels, decreased the levels of catalase in the cerebral cortex and of Sulfhydryl in the hippocampus. AYA treatment counteracted these biochemical alterations but did not display any alterations in non-stressed rats.

Conclusions: Taken together, results indicate an adaptogenic antioxidant molecular mechanism of AYA in relation to depression induced by stress.

Comparable studies

Other preclinical and animal studies on ayahuasca for depression, most cited first.

Study Year Design Participants
Understanding ayahuasca effects in major depressive disorder treatment through in vitro metabolomics and bioinformatics. Primary astrocyte cells 2023 In vitro study
Immunomodulatory and behavioral effects of ayahuasca and N, N-dimethyltryptamine in a rat model of lipopolysaccharide-induced depression. Wistar rats 2025 Randomized controlled trial n = 126
Ayahuasca partially preserves striatal integrity in juvenile non-human primates exposed to chronic stress: evidence from stereological evaluation. Marmosets (non-human primates) 2025 Controlled experiment with social isolation model n = 6
Acute antidepressant effect of ayahuasca in juvenile non-human primate model of depression Common marmosets (Callithrix jacchus) 2018 Translational animal model
Single ayahuasca administration mitigates long-term behavioral and neurochemical effects of early-life stress in rats. Wistar rats subjected to maternal deprivation as an animal model of depression 2026 Preclinical animal study (experimental)

Explore topics

By condition and practice